BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, Tapete G, Costa F. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol 2018; 24(33): 3681-3694 [PMID: 30197475 DOI: 10.3748/wjg.v24.i33.3681]
URL: https://www.wjgnet.com/1007-9327/full/v24/i33/3681.htm
Number Citing Articles
1
Lorenzo Bertani, Laura Baglietto, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Eleonora Albano, Linda Ceccarelli, Maria Gloria Mumolo, Carolina Pellegrini, Ersilia Lucenteforte, Nicola Bortoli, Massimo Bellini, Santino Marchi, Corrado Blandizzi, Francesco Costa. Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patientsBritish Journal of Clinical Pharmacology 2020; 86(7): 1296 doi: 10.1111/bcp.14235
2
Linshan Duan, Shuyu Cheng, Long Li, Yanling Liu, Dan Wang, Guoyan Liu. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel DiseaseFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.684486
3
James P. Campbell, Claudia Zierold, Ashli M. Rode, Frank A. Blocki, Byron P. Vaughn. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel SyndromeJournal of Clinical Gastroenterology 2021; 55(3): 239 doi: 10.1097/MCG.0000000000001359
4
Katharina Dihm, Malin Ek, Bodil Roth, Bodil Ohlsson. Plasma AXIN1 expression exhibit negative correlations with inflammatory biomarkers and is associated with gastrointestinal symptoms in endometriosisBiomedical Reports 2020;  doi: 10.3892/br.2020.1282
5
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll, Jon Florholmen. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkersEBioMedicine 2021; 66: 103329 doi: 10.1016/j.ebiom.2021.103329
6
Luiz G.N. de Almeida, Antoine Dufour. Proteolytic Signaling in Health and Disease2022; : 93 doi: 10.1016/B978-0-323-85696-6.00003-2
7
Carlo Morasso, Marta Truffi, Renzo Vanna, Sara Albasini, Serena Mazzucchelli, Francesco Colombo, Luca Sorrentino, Gianluca Sampietro, Sandro Ardizzone, Fabio Corsi. Raman Analysis Reveals Biochemical Differences in Plasma of Crohn’s Disease PatientsJournal of Crohn's and Colitis 2020; 14(11): 1572 doi: 10.1093/ecco-jcc/jjaa080
8
Sabrina Just Kousgaard, Thomas Yssing Michaelsen, Hans Linde Nielsen, Karina Frahm Kirk, Mads Albertsen, Ole Thorlacius-Ussing. The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch–Anal AnastomosisMicroorganisms 2020; 8(10): 1611 doi: 10.3390/microorganisms8101611
9
José Germán Sánchez-Hernández, Jonás Samuel Pérez-Blanco, Noemí Rebollo, Fernando Muñoz, Vanessa Prieto, María Victoria Calvo. Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel diseaseEuropean Journal of Pharmaceutical Sciences 2020; 150: 105369 doi: 10.1016/j.ejps.2020.105369
10
Pawel Petryszyn, Aleksandra Staniak, Agnieszka Wolosianska, Pawel Ekk-Cierniakowski. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysisEuropean Journal of Gastroenterology & Hepatology 2019; 31(11): 1306 doi: 10.1097/MEG.0000000000001509
11
Mariana del Rocio Ruiz-Briseño, Judith Carolina De Arcos-Jiménez, Sarah Ratkovich-González, Karina Sánchez-Reyes, Luz A. González-Hernández, Jaime F. Andrade-Villanueva, Monserrat Alvarez-Zavala. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ARTJournal of Inflammation 2020; 17(1) doi: 10.1186/s12950-020-00262-4
12
Eamonn M.M. Quigley. EditorialCurrent Opinion in Gastroenterology 2019; 35(1): 25 doi: 10.1097/MOG.0000000000000496
13
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitisPLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
14
Tyler McKechnie, Yung Lee, Colin Kruse, Karim Ramji, Jeremy E. Springer, Trevor Wood, Aristithes G. Doumouras, Dennis Hong, Cagla Eskicioglu. The role of fecal calprotectin in the diagnosis of acute pouchitis following IPAA for ulcerative colitis: a systematic clinical reviewInternational Journal of Colorectal Disease 2020; 35(9): 1619 doi: 10.1007/s00384-020-03669-w
15
Cecilia Suarez-Carantoña, Argeme Rodriguez-Torres, Adrian Viteri-Noel, Vicente Pintado, Sergio Garcia-Fernandez, Daniel Mora-Pimentel, Rosa Escudero-Sanchez, Fuencisla Martin-Jusdado, Santiago Moreno, Javier Cobo. Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficileJournal of Clinical Medicine 2021; 10(8): 1627 doi: 10.3390/jcm10081627
16
Daniela Fluxa, Maria T. Abreu. Therapeutic targets in inflammatory bowel diseaseRevista Médica Clínica Las Condes 2019; 30(4): 315 doi: 10.1016/j.rmclc.2019.06.008
17
Riccardo Capecchi, Paola Migliorini, Federico Zanzi, Simona Maltinti, Ilaria Puxeddu, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Santino Marchi, Lorenzo Bertani. Ig Glycosylation in Ulcerative Colitis: It’s Time for New BiomarkersFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.654319
18
Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascitesJournal of Cancer Research and Clinical Oncology 2020; 146(12): 3207 doi: 10.1007/s00432-020-03363-y
19
Macarena Gompertz, Rocío Sedano. Manifestaciones clínicas y endoscópicas en enfermedad inflamatoria intestinalRevista Médica Clínica Las Condes 2019; 30(4): 273 doi: 10.1016/j.rmclc.2019.06.002
20
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?Gastroenterología y Hepatología (English Edition) 2019; 42(5): 339 doi: 10.1016/j.gastre.2019.01.016
21
Eslam Safwat, Manar Salah, Hany Hussein. Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective studyArab Journal of Gastroenterology 2020; 21(4): 273 doi: 10.1016/j.ajg.2020.08.003
22
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa, Davide Giuseppe Ribaldone. Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel DiseasesJournal of Clinical Medicine 2020; 9(5): 1323 doi: 10.3390/jcm9051323
23
Nada Abedin, Teresa Seemann, Sandra Kleinfeld, Jessica Ruehrup, Stefani Röseler, Christian Trautwein, Konrad Streetz, Gernot Sellge. Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel DiseaseJournal of Clinical Medicine 2019; 8(12): 2025 doi: 10.3390/jcm8122025
24
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatmentEuropean Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
25
Jonas Varkey. Graft assessment for acute rejection after intestinal transplantation: current status and future perspectiveScandinavian Journal of Gastroenterology 2021; 56(1): 13 doi: 10.1080/00365521.2020.1847318
26
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative ColitisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
27
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh, Nassim Fares. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis SeverityDigestive Diseases and Sciences 2019; 64(11): 3122 doi: 10.1007/s10620-019-05675-7
28
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and RealitiesJournal of Crohn's and Colitis 2021; 15(1): 152 doi: 10.1093/ecco-jcc/jjaa093
29
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada, Atsushi Mizoguchi. A Review of Selected IBD Biomarkers: From Animal Models to BedsideDiagnostics 2021; 11(2): 207 doi: 10.3390/diagnostics11020207
30
Alain Schoepfer, Stephan R. Vavricka, Beat Brüngger, Eva Blozik, Caroline Bähler. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in SwitzerlandEuropean Journal of Gastroenterology & Hepatology 2020; 32(3): 350 doi: 10.1097/MEG.0000000000001616
31
Marnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, Muriel Stubbe, Bert Vander Cruyssen, Christina Moulakakis, Heike Berthold, Christian Konrad, Xavier Bossuyt, Lieve Van Hoovels. Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample typeClinica Chimica Acta 2021; 517: 149 doi: 10.1016/j.cca.2021.02.022
32
Erin L. Moorman, Michael Farrell, Neha Santucci, Lee Denson, Christine Le, Natoshia R. Cunningham. Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disordersBMC Research Notes 2021; 14(1) doi: 10.1186/s13104-021-05776-5
33
Lorenzo Bertani, Federico Rossari, Brigida Barberio, Maria Giulia Demarzo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Chiara Brombin, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Giorgia Bodini, Edoardo Savarino, Francesco Costa. Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioInflammatory Bowel Diseases 2020; 26(10): 1579 doi: 10.1093/ibd/izaa062
34
Sara Ramió‐Pujol, Joan Amoedo, Mariona Serra‐Pagès, Leyanira Torrealba, Anna Bahí, Marta Serrano, Marta Malagón, Gemma Ibáñez‐Sanz, Pau Gilabert, Ingrid Marin, Paola Torres, Fiorella Cañete, Miriam Mañosa, Ariadna Clos, Josep Oriol Miquel‐Cusachs, David Busquets, Míriam Sàbat, Jordi Serra, Alan C. Moss, Eugeni Domènech, Jordi Guardiola, Fermín Mearín, Javier Santos, Librado Jesús Garcia‐Gil, Xavier Aldeguer. A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controlsGastroHep 2020; 2(5): 193 doi: 10.1002/ygh2.417
35
Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park. Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitisMedicine 2021; 100(34): e27065 doi: 10.1097/MD.0000000000027065
36
Lorenzo Bertani, Corrado Blandizzi, Maria Gloria Mumolo, Linda Ceccarelli, Eleonora Albano, Gherardo Tapete, Giovanni Baiano Svizzero, Federico Zanzi, Francesca Coppini, Nicola de Bortoli, Massimo Bellini, Riccardo Morganti, Santino Marchi, Francesco Costa. Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective StudyClinical and Translational Gastroenterology 2020; 11(5): e00174 doi: 10.14309/ctg.0000000000000174
37
Julian Häger, Holger Bang, Melanie Hagen, Michael Frech, Pascal Träger, Maria V. Sokolova, Ulrike Steffen, Koray Tascilar, Kerstin Sarter, Georg Schett, Jürgen Rech, Mario M. Zaiss. The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility StudyNutrients 2019; 11(10): 2392 doi: 10.3390/nu11102392
38
Lorenzo Bertani, Matteo Fornai, Marco Fornili, Luca Antonioli, Laura Benvenuti, Gherardo Tapete, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Francesco Costa, Corrado Blandizzi. Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximabAlimentary Pharmacology & Therapeutics 2020; 52(2): 284 doi: 10.1111/apt.15870
39
Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseasesEuropean Journal of Internal Medicine 2020; 77: 105 doi: 10.1016/j.ejim.2020.03.015
40
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive MonitoringInflammatory Bowel Diseases 2020; 26(6): 961 doi: 10.1093/ibd/izz226
41
Kathrin Bausch, Elisa Roth, Stefan Heinz, David Horst, Susanne Mathia, Tatjana Vlajnic, Lukas Bubendorf, Timm Westhoff, Christian Wetterauer, Hans Helge Seifert, Jan Ebbing, Sarah P. Psutka. Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancerPLOS ONE 2019; 14(3): e0213549 doi: 10.1371/journal.pone.0213549
42
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic reviewWorld Journal of Gastroenterology 2021; 27(16): 1828-1840 doi: 10.3748/wjg.v27.i16.1828
43
Bitte Sjöström, Anders Bredberg, Thomas Mandl, Lucía Alonso-Magdalena, Bodil Ohlsson, Shahram Lavasani, Mehrnaz Nouri, Gunnel Henriksson. Increased intestinal permeability in primary Sjögren’s syndrome and multiple sclerosisJournal of Translational Autoimmunity 2021; 4: 100082 doi: 10.1016/j.jtauto.2021.100082
44
Jared Matson, Sonia Ramamoorthy, Nicole E. Lopez. The Role of Biomarkers in Surgery for Ulcerative Colitis: A ReviewJournal of Clinical Medicine 2021; 10(15): 3362 doi: 10.3390/jcm10153362
45
Shin Young Park. Age-Related Fecal Calprotectin Concentrations in Healthy AdultsThe Korean Journal of Clinical Laboratory Science 2020; 52(3): 181 doi: 10.15324/kjcls.2020.52.3.181
46
Giuseppe Acri, Valentina Venuti, Stefano Costa, Barbara Testagrossa, Salvatore Pellegrino, Vincenza Crupi, Domenico Majolino. Raman Spectroscopy as Noninvasive Method of Diagnosis of Pediatric Onset Inflammatory Bowel DiseaseApplied Sciences 2020; 10(19): 6974 doi: 10.3390/app10196974
47
Lucia Fontanelli Sulekova, Simona Gabrielli, Federica Furzi, Giovanni Luigi Milardi, Elisa Biliotti, Maurizio De Angelis, Giancarlo Iaiani, Caterina Fimiani, Myriam Maiorano, Simonetta Mattiucci, Gloria Taliani. Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonizationBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4537-7
48
Alessandro Armuzzi, Yoram Bouhnik, Fraser Cummings, Marion Bettey, Burkhard Pieper, Taegyun Kang. Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practiceDigestive and Liver Disease 2020; 52(11): 1259 doi: 10.1016/j.dld.2020.06.008
49
Valérie Sinniger, Sonia Pellissier, Florence Fauvelle, Candice Trocmé, Dominique Hoffmann, Laurent Vercueil, Jean‐Luc Cracowski, Olivier David, Bruno Bonaz. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's diseaseNeurogastroenterology & Motility 2020; 32(10) doi: 10.1111/nmo.13911
50
Matthew K. Smith, Jay Pai, Remo Panaccione, Paul Beck, Jose G. Ferraz, Humberto Jijon. Crohn’s-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case reportBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1067-0
51
Jesús K. Yamamoto-Furusho, Erick A. Mendieta-Escalante, Emiko Mizoguchi. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative ColitisPLOS ONE 2020; 15(4): e0231988 doi: 10.1371/journal.pone.0231988
52
Loredana Goran, Monica State, Ana Maria Negreanu, Lucian Negreanu. Pursuing therapeutic success in Crohn’s disease: A matter of definition, tools and longterm outcomesEuropean Journal of Inflammation 2020; 18: 205873922096289 doi: 10.1177/2058739220962896
53
Karma Yeshi, Roland Ruscher, Luke Hunter, Norelle L. Daly, Alex Loukas, Phurpa Wangchuk. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural ProductsJournal of Clinical Medicine 2020; 9(5): 1273 doi: 10.3390/jcm9051273
54
Salih TOKMAK, Ayşegül HARMANCI ÖZAKYOL. Elevated Levels of Fecal Calprotectin in Cirrhotic Patients and Spontaneous Bacterial PeritonitisDüzce Tıp Fakültesi Dergisi 2019;  doi: 10.18678/dtfd.653549
55
S. Ali Naqvi, Lorian M. Taylor, Remo Panaccione, Subrata Ghosh, Herman W. Barkema, Naomi Hotte, Nusrat Shommu, Sandeep Kaur, Raylene A. Reimer, Karen L. Madsen, Maitreyi Raman. Dietary patterns, food groups and nutrients in Crohn’s disease: associations with gut and systemic inflammationScientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80924-8
56
Elodie Picard, Frederic Antonio Carvalho, Francina Agosti, Emmanuel Bourinet, Denis Ardid, Alain Eschalier, Laurence Daulhac, Christophe Mallet. Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammationBritish Journal of Pharmacology 2019; 176(7): 950 doi: 10.1111/bph.14608
57
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa. Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative ColitisDigestive Diseases and Sciences 2020; 65(8): 2397 doi: 10.1007/s10620-019-05959-y
58
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi, Francesco Costa. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseasesMinerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02621-7
59
V. M. Makhov, L. V. Romasenko, A. S. Panferov, Yu. A. Doroninа, M. A. Isaykina, M. V. Yurazh. Clinical and psychiatric comparison of diverticular disease of the colon and irritable bowel syndromeExperimental and Clinical Gastroenterology 2020; (10): 71 doi: 10.31146/1682-8658-ecg-182-10-71-77
60
Ronald Neil Kostoff, Michael Brandon Briggs, Darja Kanduc, Darla Roye Shores, Leda Kovatsi, Alexander I. Vardavas, Alan L. Porter. Common contributing factors to COVID-19 and inflammatory bowel diseaseToxicology Reports 2021; 8: 1616 doi: 10.1016/j.toxrep.2021.08.007
61
G. Sarrabayrouse, A. Elias, F. Yáñez, L. Mayorga, E. Varela, C. Bartoli, F. Casellas, N. Borruel, C. Herrera de Guise, K. Machiels, S. Vermeire, C. Manichanh, Mariana X. Byndloss. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical SettingmSystems 2021; 6(2) doi: 10.1128/mSystems.01277-20
62
Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese, Laurent Peyrin‐Biroulet. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesUnited European Gastroenterology Journal 2021; 9(4): 451 doi: 10.1002/ueg2.12069
63
Antonio Tursi, Walter Elisei. Role of Inflammation in the Pathogenesis of Diverticular DiseaseMediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/8328490
64
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel DiseaseFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
65
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicilatos, tiopurínicos y metotrexato en la enfermedad inflamatoria intestinal, ¿es posible suspender el tratamiento?Gastroenterología y Hepatología 2019; 42(5): 339 doi: 10.1016/j.gastrohep.2019.01.013
66
Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt. Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-UpNutrients 2021; 13(4): 1083 doi: 10.3390/nu13041083
67
V. Premjeyanth, A. R. Shipman, K. E. Shipman. Faecal calprotectin in dermatology practiceClinical and Experimental Dermatology 2020; 45(7): 831 doi: 10.1111/ced.14307
68
Weifeng Wang, Lixia Wu, Xuan Wu, Ke Li, Tianming Li, Bei Xu, Weiwei Liu. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UCClinica Chimica Acta 2021; 514: 8 doi: 10.1016/j.cca.2020.12.014
69
Amy Hemperly, Marla C Dubinsky, Andres Yarur, Anita Afzali, Stephen Hanauer, Subra Kugathasan, Millie D Long, Shervin Rabizadeh, Robbyn Sockolow, Lauren Okada, Anjali Jain, Maria T Abreu, Niels Vande Casteele. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug MonitoringCrohn's & Colitis 360 2021; 3(3) doi: 10.1093/crocol/otab035
70
Lluís Puig. The safety of ixekizumab in psoriasis drug therapyExpert Opinion on Drug Safety 2020; 19(2): 117 doi: 10.1080/14740338.2020.1709440